MIT BOTULINUMTOXIN VORGEFÜLLTES SPRITZENSYSTEM

Patent europeic · EP3474931 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3474931
Numer da la dumonda
EP17733769
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-06-2017
Publitgà
01-05-2019
Concedì
24-09-2025
La protecziun finescha il pli tard
19-06-2037
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
A61M 5/315 (2006.01)
A61M 5/178 (2006.01)
Prioritad
EP 16001404 22.06.2016
Dumonda PCT
PCT/EP2017/065050 20.06.2017
Publicaziun PCT
WO2017/220553 28.12.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 05-08-2026

    Midada

    Published in Swissreg on 05.08.2026

  2. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  3. 24-09-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.09.2025

Partidas

Possessur

Merz Pharma GmbH & Co. KGaA

Eckenheimer Landstrasse 100, 60318 Frankfurt am Main, DE

Inventur

VOGT, Markus

60438 Frankfurt am Main, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.